Skip to main content
SpringerLink
Log in

26. Liraglutide Reverses Pronounced Insulin-Associated Weight Gain, Improves Glycemic Control, and Decreases Insulin Dose in Patients with Type 2 Diabetes (973-P)

  • Congresverslag
  • Published:
Nederlands Tijdschrift voor Diabetologie Aims and scope

Samenvatting

Insulin-induced weight gain, often occurring over the first 9-12 months after starting insulin in patients with type 2 diabetes (T2DM), is obviously undesirable in an already overweight population and may offset the beneficial effects of insulin. We hypothesized that addition of liraglutide may be especially effective in reversing body weight in patients with pronounced insulin-associated weight gain while preserving glycemic control. This hypothesis was tested in a randomized controlled trial (ELEGANT).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. http://www.bsl.nl

    Helena de Wit, Gerald M. Vervoort, Henry J. Jansen, Wim J.C. de Grauw, Bastiaan E. de Galan & Cees J. Tack

Authors
  1. Helena de Wit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerald M. Vervoort
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henry J. Jansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wim J.C. de Grauw
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bastiaan E. de Galan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cees J. Tack
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Nijmegen, Netherlands, ‘s-Hertogenbosch, Netherlands

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Wit, H., Vervoort, G., Jansen, H. et al. 26. Liraglutide Reverses Pronounced Insulin-Associated Weight Gain, Improves Glycemic Control, and Decreases Insulin Dose in Patients with Type 2 Diabetes (973-P). NED. TIJDSCHR. DIABET. 12, 29 (2014). https://doi.org/10.1007/s12467-014-0051-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12467-014-0051-0

Search

Navigation